NCM
Nantahala Capital Management’s Avalo Therapeutics AVTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.97M | Buy |
995,000
+95,000
| +11% | +$474K | 0.19% | 78 |
|
|
2025
Q1 | $7.21M | Buy |
+900,000
| New | +$7.21M | 0.29% | 45 |
|
|
2023
Q3 | – | Sell |
-556,202
| Closed | -$198K | – | 115 |
|
|
2023
Q2 | $198K | Sell |
556,202
-252,642
| -31% | -$89.7K | 0.02% | 98 |
|
|
2023
Q1 | $1.42M | Buy |
808,844
+268,177
| +50% | +$469K | 0.11% | 75 |
|
|
2022
Q4 | $2.73M | Sell |
540,667
-7,147
| -1% | -$36K | 0.18% | 59 |
|
|
2022
Q3 | $1.82M | Sell |
547,814
-6,162,513
| -92% | -$20.5M | 0.12% | 64 |
|
|
2022
Q2 | $3.36M | Sell |
6,710,327
-139,220
| -2% | -$69.6K | 0.17% | 54 |
|
|
2022
Q1 | $4.8M | Sell |
6,849,547
-296,327
| -4% | -$208K | 0.21% | 54 |
|
|
2021
Q4 | $12.1M | Buy |
7,145,874
+193,473
| +3% | +$329K | 0.43% | 34 |
|
|
2021
Q3 | $15.2M | Buy |
6,952,401
+626,724
| +10% | +$1.37M | 0.48% | 35 |
|
|
2021
Q2 | $20.7M | Sell |
6,325,677
-1,325,251
| -17% | -$4.33M | 0.59% | 28 |
|
|
2021
Q1 | $23.1M | Buy |
7,650,928
+1,417,612
| +23% | +$4.28M | 0.68% | 26 |
|
|
2020
Q4 | $16.5M | Buy |
6,233,316
+441,366
| +8% | +$1.17M | 0.51% | 38 |
|
|
2020
Q3 | $13.2M | Buy |
5,791,950
+110,546
| +2% | +$251K | 0.4% | 44 |
|
|
2020
Q2 | $14.8M | Buy |
+5,681,404
| New | +$14.8M | 0.45% | 35 |
|